Feasibility of Tumor-Informed Circulating Tumor DNA (ctDNA) for Molecular Residual Disease (MRD) Assessment in Pediatric Patients with Solid Published Date June 4, 2024 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen
